Oncology Information Systems Market is Estimated to Witness High Growth Owing to Opportunity to Improve Patient Care
Oncology information
systems (OIS) are specialized medical software used for oncology practices to
manage patient care, billing, treatment plans, and more. OIS help streamline
complex workflows by integrating scheduling, billing, clinical management, and
reporting functionalities into a unified system. This allows care teams to save
time navigating between multiple systems while providing personalized care
plans and coordinated treatment for cancer patients.
The global Oncology Information Systems
Market is estimated to be valued at US$ 8.19 Bn in 2023 and is expected to
exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in
a new report published by Coherent Market Insights.
Market Opportunity:
The opportunity to improve patient care lies at the core of Oncology Information
Systems market growth. By accessing comprehensive patient histories, treatment
plans, medical imaging and test results digitally through OIS, oncologists can
better evaluate disease progression and provide targeted therapies. This leads
to improved clinical outcomes. Additionally, care coordination is enhanced
through role-based dashboards and workflows in OIS. Streamlined communication
across care teams allows for timely interventions, follow-ups and management of
side effects. Overall, OIS enable precision medicine approaches and
patient-centric care models critical for effective cancer treatment. This
growing demand for improved patient outcomes is a key driver propelling the
Oncology Information Systems market forward.
Porter's Analysis
Threat of new entrants: The global oncology information systems market requires
high upfront capital costs to develop specialized software. Long development
timelines along with significant R&D investments pose threat of new
entrants.
Bargaining power of buyers: The number of buyers in the global oncology
information systems market is large comprising hospitals, oncology clinics, and
private practices. Individual buyers have low bargaining power due to need of
specialized oncology software systems.
Bargaining power of suppliers: A few companies dominate the supply of oncology
information systems. This gives them significant bargaining power over buyers
in terms of pricing and aftersales support.
Threat of new substitutes: There exists a medium threat of substitution from
emerging alternative technologies like artificial intelligence and automation
solutions catering to oncology data management needs.
Competitive rivalry: The global market witnesses intense competition among
existing key players investing in new product innovations and strategic
collaborations.
SWOT Analysis
Strength: Specialized clinical functionality and ability to integrate with
other hospital information systems. Growing adoption of electronic health
records supports market growth.
Weakness: High costs associated with purchase, maintenance and upgradation.
Requires trained professionals for operations.
Opportunity: Untapped growth potential in developing regions. Growing cancer
patient pool and increasing count of cancer care facilities drive
opportunities.
Threats: Data privacy and security concerns limit demand. Interoperability
issues pose challenges in seamless information exchange.
Key Takeaways
Global
Oncology Information Systems Market Size is expected to witness high
growth supported by growing cancer prevalence worldwide. The Asia Pacific
region is projected to grow at the fastest pace during the forecast period.
Increasing healthcare investments by governments and expanding private
healthcare sector in China, India and other emerging economies will drive
regional market growth.
Key players operating in the global oncology information systems market are
Merck & Co., Inc., Novartis AG, Amicus Therapeutics, AstraZeneca Plc,
Boehringer Ingelheim, Shire Plc, Sanofi Genzyme, BioMarin Pharmaceutical, Inc.,
Horizon Pharma Plc, and GlaxoSmithKline Plc. These companies are focusing on
new product launches and strategic collaborations to enhance their market
share. For instance, In 2023, Elekta launched MOSAIQ Oncology Information
System to provide enhanced interoperability and data exchange capabilities
across cancer care facilities.
Get More Insights on this Topic- https://www.dailyprbulletin.com/oncology-information-systems-market-forecast-analysis-and-insights/
Comments
Post a Comment